Antibodies against antibodies: immunogenicity of adalimumab as a model
| Authors |
|
|---|---|
| Supervisors |
|
| Cosupervisors |
|
| Award date | 16-11-2012 |
| ISBN |
|
| Number of pages | 148 |
| Organisations |
|
| Abstract | Upon repeated adalimumab exposure part of the patients start to produce ADA. The antibody response is polyclonal and consists mainly of antibodies of IgG1 and IgG4 isotype. In the majority of ADA positive patients ADA are already produced within the first 28 weeks of treatment and in part of the patients antibody production is transient. All antibodies are directed against the idiotype of adalimumab and result in functional neutralization of the drug. |
| Document type | PhD thesis |
| Note | Research conducted at: Universiteit van Amsterdam |
| Language | English |
| Downloads | |
| Permalink to this page | |
